The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

HIK HIKMA PHARMACEUTICALS PLC ORD SHS 10P




 Page 2 of 3

Previous | 1 | 2 | 3 | Next

Time/Date Code Headline Source Impact
11:08 26-Feb-2019 HIK Notice of Results RNS -0.60% Down
10:11 11-Feb-2019 HIK Director/PDMR Shareholding RNS +4.26% Up
15:43 01-Feb-2019 HIK Total Voting Rights RNS +6.86% Up
09:00 29-Jan-2019 HIK Hikma launches Mitomycin for Injection RNS +3.84% Up
09:00 03-Jan-2019 HIK Hikma announces agreement with Sciecure Pharma RNS -3.78% Down
09:00 10-Dec-2018 HIK Hikma launches Clobazam RNS +2.54% Up
10:30 03-Dec-2018 HIK Total Voting Rights RNS -0.17% Down
09:00 27-Nov-2018 HIK Hikma announces injectable licensing agreement RNS +4.71% Up
09:00 19-Nov-2018 HIK Hikma launches Triazolam Tablets RNS -5.26% Down
11:15 13-Nov-2018 HIK Holding(s) in Company RNS -
09:44 08-Nov-2018 HIK Hikma announces agreement with Vectura RNS -3.93% Down
07:00 08-Nov-2018 HIK Hikma announces agreement with Vectura RNS -3.93% Down
07:00 08-Nov-2018 HIK Trading Statement RNS -3.93% Down
12:39 01-Nov-2018 HIK Total Voting Rights RNS +3.64% Up
16:30 16-Oct-2018 HIK Block listing Interim Review RNS +3.04% Up
10:53 01-Oct-2018 HIK Total Voting Rights RNS +1.09% Up
10:23 01-Oct-2018 HIK Holding(s) in Company RNS +1.09% Up
11:05 03-Sep-2018 HIK Total Voting Rights RNS +0.39% Up
09:58 30-Aug-2018 HIK Holding(s) in Company RNS +3.58% Up
12:45 28-Aug-2018 HIK Holding(s) in Company RNS +3.57% Up

 Page 2 of 3

Previous | 1 | 2 | 3 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Company Information
Company website http://www.hikma.com
Company address 1 New Burlington Place, London, W1S 2HR, United Kingdom
FTSE ICB sector Pharmaceuticals & Biotechnology
FTSE ICB subsector Pharmaceuticals
Company market cap, £m* 4,217.42
Admission date 04 Nov 2005
*The company market capitalization reflects the London listed element of Ordinary and Preference shares only and is approximate. Data provided by FTSE Russell.

Security Information
FTSE index FTSE 100,FTSE 350,FTSE 350 Low Yield,FTSE 350 (ex IT),FTSE All-Share,FTSE All-Share (ex IT),FTSE Euromid
Market Main Market
Market identifier code (MIC) XLON
Trading service SETS
Trading segment SET1
Listing category Premium Equity Commercial Companies
Country of share register GB
ISIN GB00B0LCW083
SEDOL B0LCW08
Exchange market size 1,000
Security market cap, £m 4,217.42
*The market capitalisation of the security reflects data from previous trading day.


HIKMA share news analysis (HIK)